Cargando…
Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice
Liposomal nanotechnology has a great potential to overcome the current major problems of chemotherapy. However, the lack of penetrability and targetability retards the successful delivery of liposomal carriers. Previously, we showed that BR2 peptide modification endowed cantharidin-loaded liposomes...
Autores principales: | Zhang, Xue, Lin, Congcong, Chan, Waikei, Liu, Kanglun, Lu, Aiping, Lin, Ge, Hu, Rong, Shi, Hongcan, Zhang, Hongqi, Yang, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767275/ https://www.ncbi.nlm.nih.gov/pubmed/31547459 http://dx.doi.org/10.3390/molecules24183332 |
Ejemplares similares
-
Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma
por: Zhang, Xue, et al.
Publicado: (2017) -
The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
por: Ng, Huei Leng Helena, et al.
Publicado: (2014) -
Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy
por: Lin, Congcong, et al.
Publicado: (2017) -
Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro
por: Wong, Blenda Chi Kwan, et al.
Publicado: (2014) -
Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation
por: Zhang, Xue, et al.
Publicado: (2017)